Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 27, 2026
Aridis Pharmaceuticals Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $5.33 thousand as of July 31, 2026.
Market Cap
5.33K
Enterprise Value
n/a
Revenue
22.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from 102.57M to 5.33K, a decrease of -99.99%. That is a compound annual growth rate of -71.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 5.33K | -93.33% |
| Dec 31, 2025 | 79.98K | 1,400.02% |
| Dec 31, 2024 | 5.33K | -99.83% |
| Dec 29, 2023 | 3.18M | -89.17% |
| Dec 30, 2022 | 29.39M | -10.24% |
| Dec 31, 2021 | 32.75M | -46.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovAccess Global | 6.17K |
| Theralink Technologies | 6.15K |
| MetaStat | 5.88K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| LadRx | 5.45K |
| Iterum Therapeutics | 5.28K |